NRG Oncology
![speaker image](/_next/image?url=https%3A%2F%2Fcoatconnect-files.s3.amazonaws.com%2FDev%2FCover-8da94522-078e-44d1-813b-6e6f440d33db-764c7cfd-3859-4722-b037-b51b93ec62cf-speakers-nrg-oncology.webp%3FAWSAccessKeyId%3DAKIAJTMHAFAXQLGGIHMA%26Expires%3D1830762018%26Signature%3DD3u3Z0qMTRBqZP%252B18w033FFhC6g%253D&w=3840&q=75)
NRG Oncology is a non-profit research organization formed to conduct oncologic clinical research and to broadly disseminate study results for informing clinical decision making and healthcare policy. It brings together the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG) - each recognized internationally as a research leader.
NRG Oncology embodies an impressive legacy in the conduct of multi-institutional phase II and phase III clinical trials and a history of undertaking phase I and translational biological studies imperative for oncologic research of the future.
Mission:
Improve the lives of patients with cancer by conducting practice-changing multi-institutional clinical and translational research